Výsledky vyhledávání - Piris, Adriano
- Zobrazuji výsledky 1 - 16 z 16
-
1
-
2
Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families Autor Njauw, Ching-Ni Jenny, Kim, Ivana, Piris, Adriano, Gabree, Michele, Taylor, Michael, Lane, Anne Marie, DeAngelis, Margaret M., Gragoudas, Evangelos, Duncan, Lyn M., Tsao, Hensin
Vydáno 2012Text -
3
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes Autor Cooper, Zachary A, Frederick, Dennie T, Juneja, Vikram R, Sullivan, Ryan J, Lawrence, Donald P, Piris, Adriano, Sharpe, Arlene H, Fisher, David E, Flaherty, Keith T, Wargo, Jennifer A
Vydáno 2013Text -
4
Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma Autor Shen, Che-Hung, Kim, Sun Hye, Trousil, Sebastian, Frederick, Dennie T., Piris, Adriano, Yuan, Ping, Cai, Li, Gu, Lei, Li, Man, Lee, Jung Hyun, Mitra, Devarati, Fisher, David E., Sullivan, Ryan J., Flaherty, Keith T., Zheng, Bin
Vydáno 2016Text -
5
Cutaneous mucormycosis arising in the skin folds of immunocompromised patients: A case series Autor Rrapi, Renajd, Chand, Sidharth, Gaffney, Rebecca, Lo, Jennifer A., Smith, Jeffrey S., Xia, Fan Di, Chen, Steven T., Duncan, Lyn M., Foreman, Ruth K., Hartman, Rebecca I., Hoang, Mai P., Piris, Adriano, Walls, Andrew C., Kroshinsky, Daniela
Vydáno 2021Text -
6
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma Autor Mooradian, Meghan J., Reuben, Alexandre, Prieto, Peter A., Hazar-Rethinam, Mehlika, Frederick, Dennie T., Nadres, Brandon, Piris, Adriano, Juneja, Vikram, Cooper, Zachary A., Sharpe, Arlene H., Corcoran, Ryan B., Flaherty, Keith T., Lawrence, Donald P., Wargo, Jennifer A., Sullivan, Ryan J.
Vydáno 2018Text -
7
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade Autor Cooper, Zachary A., Juneja, Vikram R., Sage, Peter T., Frederick, Dennie T., Piris, Adriano, Mitra, Devarati, Lo, Jennifer A., Hodi, F. Stephen, Freeman, Gordon J., Bosenberg, Marcus W., McMahon, Martin, Flaherty, Keith T., Fisher, David E., Sharpe, Arlene H., Wargo, Jennifer A.
Vydáno 2014Text -
8
RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors Autor Oberholzer, Patrick A., Kee, Damien, Dziunycz, Piotr, Sucker, Antje, Kamsukom, Nyam, Jones, Robert, Roden, Christine, Chalk, Clinton J., Ardlie, Kristin, Palescandolo, Emanuele, Piris, Adriano, MacConaill, Laura E., Robert, Caroline, Hofbauer, Günther F.L., McArthur, Grant A., Schadendorf, Dirk, Garraway, Levi A.
Vydáno 2012Text -
9
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib Autor Corcoran, Ryan B., Ebi, Hiromichi, Turke, Alexa B., Coffee, Erin M., Nishino, Michiya, Cogdill, Alexandria P., Brown, Ronald D., Pelle, Patricia Della, Dias-Santagata, Dora, Hung, Kenneth E., Flaherty, Keith T., Piris, Adriano, Wargo, Jennifer A., Settleman, Jeffrey, Mino-Kenudson, Mari, Engelman, Jeffrey A.
Vydáno 2012Text -
10
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma Autor Starrett, Gabriel J., Thakuria, Manisha, Chen, Tianqi, Marcelus, Christina, Cheng, Jingwei, Nomburg, Jason, Thorner, Aaron R., Slevin, Michael K., Powers, Winslow, Burns, Robert T., Perry, Caitlin, Piris, Adriano, Kuo, Frank C., Rabinowits, Guilherme, Giobbie-Hurder, Anita, MacConaill, Laura E., DeCaprio, James A.
Vydáno 2020Text -
11
TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma Autor Corcoran, Ryan B., Rothenberg, Stephen Michael, Hata, Aaron N., Faber, Anthony C., Piris, Adriano, Nazarian, Rosalynn M., Brown, Ronald D., Godfrey, Jason T., Winokur, Daniel, Walsh, John, Mino-Kenudson, Mari, Maheswaran, Shyamala, Settleman, Jeffrey, Wargo, Jennifer A., Flaherty, Keith T., Haber, Daniel A., Engelman, Jeffrey A.
Vydáno 2013Text -
12
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors Autor Konieczkowski, David J., Johannessen, Cory M., Abudayyeh, Omar, Kim, Jong Wook, Cooper, Zachary A., Piris, Adriano, Frederick, Dennie T., Barzily-Rokni, Michal, Straussman, Ravid, Haq, Rizwan, Fisher, David E., Mesirov, Jill P., Hahn, William C., Flaherty, Keith T., Wargo, Jennifer A., Tamayo, Pablo, Garraway, Levi A.
Vydáno 2014Text -
13
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming Autor Chu, Zhaowei, Gu, Lei, Hu, Yeguang, Zhang, Xiaoyang, Li, Man, Chen, Jiajia, Teng, Da, Huang, Man, Shen, Che-Hung, Cai, Li, Yoshida, Toshimi, Qi, Yifeng, Niu, Zhixin, Feng, Austin, Geng, Songmei, Frederick, Dennie T., Specht, Emma, Piris, Adriano, Sullivan, Ryan J., Flaherty, Keith T., Boland, Genevieve M., Georgopoulos, Katia, Liu, David, Shi, Yang, Zheng, Bin
Vydáno 2022Text -
14
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma Autor Frederick, Dennie Tompers, Piris, Adriano, Cogdill, Alexandria P., Cooper, Zachary A., Lezcano, Cecilia, Ferrone, Cristina R., Mitra, Devarati, Boni, Andrea, Newton, Lindsay P., Liu, Chengwen, Peng, Weiyi, Sullivan, Ryan J, Lawrence, Donald P., Hodi, F. Stephen, Overwijk, Willem W., Lizée, Gregory, Murphy, George F., Hwu, Patrick, Flaherty, Keith T., Fisher, David E., Wargo, Jennifer A.
Vydáno 2013Text -
15
Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma Autor Simpson, R Mark, Bastian, Boris C, Michael, Helen T, Webster, Joshua D, Prasad, Manju L, Conway, Catherine M, Prieto, Victor M, Gary, Joy M, Goldschmidt, Michael H, Esplin, D Glen, Smedley, Rebecca C, Piris, Adriano, Meuten, Donald J, Kiupel, Matti, Lee, Chyi-Chia R, Ward, Jerrold M, Dwyer, Jennifer E, Davis, Barbara J, Anver, Miriam R, Molinolo, Alfredo A, Hoover, Shelley B, Rodriguez-Canales, Jaime, Hewitt, Stephen M
Vydáno 2014Text -
16
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids Autor Jenkins, Russell W., Aref, Amir R., Lizotte, Patrick H., Ivanova, Elena, Stinson, Susanna, Zhou, Chensheng W., Bowden, Michaela, Deng, Jiehui, Liu, Hongye, Miao, Diana, He, Meng Xiao, Walker, William, Zhang, Gao, Tian, Tian, Cheng, Chaoran, Wei, Zhi, Palakurthi, Sangeetha, Bittinger, Mark, Vitzthum, Hans, Kim, Jong Wook, Merlino, Ashley, Quinn, Max, Venkataramani, Chandrasekar, Kaplan, Joshua A., Portell, Andrew, Gokhale, Prafulla C., Phillips, Bart, Smart, Alicia, Rotem, Asaf, Jones, Robert E., Keogh, Lauren, Anguiano, Maria, Stapleton, Lance, Jia, Zhiheng, Barzily-Rokni, Michal, Cañadas, Israel, Thai, Tran C., Hammond, Marc R., Vlahos, Raven, Wang, Eric S., Zhang, Hua, Li, Shuai, Hanna, Glenn J., Huang, Wei, Hoang, Mai P., Piris, Adriano, Eliane, Jean-Pierre, Stemmer-Rachamimov, Anat O., Cameron, Lisa, Su, Mei-Ju, Shah, Parin, Izar, Benjamin, Thakuria, Manisha, LeBoeuf, Nicole R., Rabinowits, Guilherme, Gunda, Viswanath, Parangi, Sareh, Cleary, James M., Miller, Brian C., Kitajima, Shunsuke, Thummalapalli, Rohit, Miao, Benchun, Barbie, Thanh U., Sivathanu, Vivek, Wong, Joshua, Richards, William G., Bueno, Raphael, Yoon, Charles H., Miret, Juan, Herlyn, Meenhard, Garraway, Levi A., Van Allen, Eliezer M., Freeman, Gordon J., Kirschmeier, Paul T., Lorch, Jochen H., Ott, Patrick A., Hodi, F. Stephen, Flaherty, Keith T., Kamm, Roger D., Boland, Genevieve M., Wong, Kwok-Kin, Dornan, David, Paweletz, Cloud Peter, Barbie, David A.
Vydáno 2017Text